Germany's BioNTech on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb in a cancer immunotherapy alliance that seeks to challenge ...

Pharmaceutical marketing has often been viewed through the lens of process and execution – campaigns, timelines, approvals.

The last quarter of each year brings us a new iPhone family. They arrive as reliably as your birthday. And certainly more reliably than your friends remembering it. But does the iPhone 17 mark the ...

This year, BMS partnered to develop a PD-L1 and VEGF bispecific antibody and has acquired the rights to a new radiopharmaceutical asset.